Monitor Ventures Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Bill Radvak
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.3yrs |
| CEO ownership | n/a |
| Management average tenure | 11.3yrs |
| Board average tenure | 12.4yrs |
Recent management updates
Recent updates
CEO
Bill Radvak (60 yo)
14.3yrs
Tenure
Mr. William Joseph Radvak, also known as Bill, BASc, served as Interim Chief Executive Officer at NervGen Pharma Corp. since September 23, 2022 until April 10, 2023. He served as Chief Executive Officer at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 14.3yrs | no data | no data | |
| Chief Financial Officer | 12.7yrs | no data | no data | |
| Director of Corporate Finance | no data | no data | no data | |
| Vice President of Sales | 9.9yrs | no data | no data | |
| Corporate Secretary | 1.3yrs | no data | no data |
11.3yrs
Average Tenure
59yo
Average Age
Experienced Management: AVCV.F's management team is seasoned and experienced (11.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 14.3yrs | no data | no data | |
| Independent Director | 18.1yrs | no data | no data | |
| Independent Director | 7.8yrs | no data | no data | |
| Independent Chairman of the Board | 10.6yrs | no data | 0.68% CA$ 1.3k |
12.4yrs
Average Tenure
65yo
Average Age
Experienced Board: AVCV.F's board of directors are seasoned and experienced ( 12.4 years average tenure).